US-based health analytics marketplace Apervita closed an $18m series A round co-led by GE Ventures, the corporate venturing arm of conglomerate General Electric, on Wednesday.
Venture capital and private equity firm Baird Capital co-led the round, which included funding from Pritzker Group Venture Capital, Math Ventures and undisclosed existing investors.
Apervita had targeted $26m from the round, according to a regulatory filing last month, made under its previous name of Pervasive Health. The company previously secured $1.6m in debt financing in 2012 and $1.4m in a 2013 seed round.
Apervita has developed an online analytics platform that consolidates the knowledge of healthcare professionals from around the world and converts it to computable datasets.
The platform can assist professionals with challenges such as chronic disease management, the prevention side effects or increasing the quality of care. Apervita will use the proceeds from the round to expand its sales and marketing team.
Medical care provider and researcher Mayo Clinic, one of the companies working with the platform, has used it to develop an application to that can identify high-risk patients in need of an implantable cardiac defibrillator.